• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number HT087080J
Device Problem Torn Material (3024)
Patient Problems Fall (1848); Laceration(s) (1946)
Event Date 03/26/2015
Event Type  Injury  
Event Description
The following was reported to gore: the patient underwent vascular graft replacement of the popliteal artery on (b)(6) 2015.The patient fell, twisting his previously treated leg on (b)(6) 2015.A circumferential tear at the distal end of the graft along the suture line was noted.On (b)(6) 2015, the torn portion of the graft was explanted and replaced with a new gore® propaten® vascular graft.The patient is doing well.
 
Manufacturer Narrative
Review of the manufacturing records verified that the lot met release requirements.Examination of the returned device is in process.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
Summary of returned device evaluation: the returned device was subjected to an acid digestion process to remove biologic debris.Following digestion, the device was examined for material disruptions with the aid of a stereomicroscope.The device was then prepared for scanning electron microscopy (sem) using platinum sputter coating and examined.Disruptions identified were not associated with handling or manufacturing process at wl gore and associates.The disruptions are consistent with a surgical procedure.Marks consistent with a surgical instrument are present on the abluminal surface.Pull through of the anastomotic sutures and an area of graft rupture were identified.The suture pull tracks and their associated angles, and section of graft rupture indicate that the anastomotic site was subjected to sudden tension in multiple directions.The instructions for use state: caution the patient against extreme or abrupt movements of the arm, shoulder, or legs during a convalescent period of six-to-eight weeks to allow for adequate healing.Routine activities such as reaching out in front, raising arms above the shoulder level, throwing, pulling, striding, or twisting should be avoided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE PROPATEN® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
craig bearchell
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4719774
MDR Text Key5579851
Report Number2017233-2015-00251
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K062161
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative,company representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 08/14/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/22/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2017
Device Catalogue NumberHT087080J
Device Lot Number4262988PP024
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/16/2015
Is the Reporter a Health Professional? No
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/19/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age84 YR
Patient Weight52
-
-